Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight The...
-
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight The microbial fermentation...
-
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight LEQEMBI (lecanemab) has significant...
-
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- JAK Inhibitors Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight |...
-
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Growth at a CAGR of ~24% by 2032 | DelveInsight The...
-
New York, USA, March 03, 2025 (GLOBE NEWSWIRE) -- Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment...
-
New York, USA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NK Cell Therapy Market on Track for Exponential Growth Amid Rising Pipeline Developments | DelveInsight The NK cell therapy market is experiencing...
-
New York, USA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Global Blood Bank Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight The rising incidence of blood disorders and chronic...
-
New York, USA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Pharma Competitive Benchmarking – How a Pharma Leader Gained a Strategic Edge with DelveInsight A competitor analysis case study on how DelveInsight...
-
New York, USA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- OPZELURA Continues to Revolutionize the Dermatology Market with Strong Market Uptake | DelveInsight OPZELURA (ruxolitinib cream) has shown strong...